Skip to content

Comparison of Three Techniques for Analgesia After Abdominoplasty

The Efficacy of Three Different Surgically Infiltrated Local Anesthetic Techniques in Abdominoplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03077581
Acronym
Maha1
Enrollment
48
Registered
2017-03-13
Start date
2017-03-01
Completion date
2017-06-15
Last updated
2017-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominoplasty Patients

Brief summary

This study was conducted to demonstrate post-abdominoplasty analgesic duration consequent to three different surgically infiltrated LA techniques; bilateral TAPB, bilateral RSB and subcutaneous infiltration using the same volume of 0.25% bupivacaine (40 ml). Pain score, total analgesic rescue requests and the total amount of systemic rescue analgesia used in the first postoperative day in addition to any detected postoperative complications were also recorded.

Interventions

DRUGTransevrsus abdominus plane block

a blunt needle was advanced in the midaxillary line to reach the fascial layer between the internal oblique and transverse abdominis muscles detected by facial click sensation. The LA was slowly injected so as to detect any sign of toxicity or incorrect needle tip position (as resistance) requiring needle repositioning then TAPB was repeated on the opposite side.

DRUGRectus sheath block

In RSB group, 2-3 cm from midline, about 3-5 cm above the umbilicus, the needle was advanced at right angle to the skin. The needle reaches the space between the posterior layer of the rectus sheath and rectus abdominis muscle detected by firm resistance of the posterior wall, The LA was slowly injected then the same steps were repeated on the other side.

DRUGlocal anesthesia infiltartion

40 mls of 0.255 bupivacaine will be infiltrated at skin incision

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* all patients listed for abdominoplasty

Exclusion criteria

* allergy to bupivacaine

Design outcomes

Primary

MeasureTime frameDescription
morphine consumption (mg)up to 24 hourspostoperative morphine consumption in milligrams in the 1st 24 hours postoperatively

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026